返回
Micro-volume wall-less immunoassays using patterned planar plates
DOI:10.1039/c3lc40973b.png)
摘要
En 中文
Miniaturization of immunoassays has numerous potential advantages over traditional ELISAs. Here we present a novel approach using patterned planar plates (PPPs). These 'wall-less' plates consist of a 16624 array of 2 mm diameter hydrophilic regions surrounded by a hydrophobic polytetrafluoroethylene (PTFE) coating. Assays are performed by adding 2 mu L droplets to the hydrophilic areas. These droplets are overlaid with an immiscible mixture of perfluorocarbon liquid (PFCL) that essentially eliminates evaporation. During wash steps, a thin film of PFCL covers the hydrophobic coating and prevents its wetting by wash buffer; as a result, the hydrophilic wells remain intact and inter-well cross-contamination is prevented. We compared the performance of three immunoassays using PPPs versus traditional 384-well ELISA plates. These included assays for soluble FcRH5 in human serum, SDF-1 in mouse serum, and human IgG in mouse plasma. The results show that the PPP assays were closely comparable to the ELISAs in terms of sensitivity, linearity of dilution, and sample quantitation. Moreover, the PPP assays were rapid to perform, easily adapted from ELISA protocols, and used 10- to 50-fold less sample and reagent volume as compared to 384- or 96-well plate ELISAs. As an additional advantage, PPPs conform to established microplate dimensional standards making them compatible with pre-existing equipment and workflows. PPPs therefore represent an attractive and broadly applicable approach to flexible miniaturization of plate-based immunochemical assays.
Keyword:
PROTEIN
MICROARRAY
ASSAYS
CELLS
ARRAYS
AI总结
对已上传原文的论文进行重点信息的提取,主要内容包括:简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
L
IF:
5.4
论文数:
9.0K
被引数:
3.3W
机构
引用论文
Evaluating sandwich immunoassays in microarray format in terms of the ambient analyte regime
CLINICAL CHEMISTRY
IF6.3
Microfabricated arrays of femtoliter chambers allow single molecule enzymology
NATURE BIOTECHNOLOGY
IF41.7
Protein biomarker discovery and validation: the long and uncertain path to clinical utility
NATURE BIOTECHNOLOGY
IF41.7

